We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.


Global leaders commit to act on antimicrobial resistance – one of the highlighted approaches is to develop and use rapid diagnostic tests

Yesterday, on September 21, heads of state gathered with doctors and other experts at the United Nations General Assembly for a high-level meeting on antimicrobial resistance. To develop and use rapid diagnostic tests is one of the proposed actions.

According to the UN, world leaders signaled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines. For the first time, Heads of State committed to taking a broad, coordinated approach to address the root causes of AMR across human health, animal health and agriculture. This is only the fourth time a health issue has been taken up by the UN General Assembly (the others were HIV, noncommunicable diseases, and Ebola). The high-level meeting was convened by the President of the 71st session of the UN General Assembly, H.E. Peter Thomson. At the meeting Mr. Thomson said that “antimicrobial resistance threatens the achievement of the Sustainable Development Goals and requires a global response” and continued, that “Member States have agreed upon a strong Political declaration that provides a good basis for the international community to move forward. No one country, sector or organization can address this issue alone.”

The participants pledged to strengthen regulation of antimicrobials, improve knowledge and awareness, and promote best practices — as well as to foster innovative approaches using alternatives to antimicrobials and new technologies for diagnosis and vaccines. They as well called for new incentives for investment in research and development of new, effective and affordable medicines and rapid diagnostic tests.

The UN. Press release: High-Level Meeting on Antimicrobial Resistance. 21.9.2016. http://www.un.org/pga/71/2016/09/21/press-release-hl-meeting-on-antimicrobial-resistance/ 


QuikRead go® CRP

Test before prescribing

QuikRead go CRP is a fast and simple rapid test for quantitative determination of C-reactive protein (CRP) in whole blood, serum and plasma with the QuikRead go instrument. The test gives reliable results within minutes and speeds up the path to the right diagnosis. Accurate measurement of C-reactive protein (CRP) can be critical in the clinical management of a patient with symptoms of infection. Read more: QuikRead go CRP and QuikRead go CRP+Hb